Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 88
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Int J Oral Maxillofac Surg ; 50(11): 1413-1421, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33663900

RESUMEN

The purpose of this study was to investigate the prognostic value of prognostic nutritional index (PNI) in oral squamous cell carcinoma (OSCC) patients and to undertake a comparative evaluation of the prognostic value of comparing PNI, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in terms of prognostic utility. A retrospective study was conducted involving 203 consecutive patients with OSCC who were treated with radical surgery with curative intent. The PNI and systemic inflammatory response were developed, and their prognostic utility was evaluated. Kaplan-Meier curve analysis and log-rank testing showed that PNI (P< 0.001), NLR (P=0.011), PLR (P=0.013), and LMR (P=0.014) were significantly associated with overall survival. Multivariate analysis identified PNI as an independent prognostic factor for OSCC patients (P=0.029). In time-dependent receiver operating characteristic curve analysis, PNI was continuously superior to that of NLR, PLR, and LMR. In conclusion, this study suggested that PNI offered an independent prognostic biomarker in OSCC patients undergoing radical surgery. However, this study was small and retrospective, thus further investigations are needed to clarify the utility of PNI for tailor-made treatments in clinical settings.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de Cabeza y Cuello , Neoplasias de la Boca , Carcinoma de Células Escamosas/cirugía , Humanos , Neoplasias de la Boca/cirugía , Neutrófilos , Evaluación Nutricional , Pronóstico , Estudios Retrospectivos , Carcinoma de Células Escamosas de Cabeza y Cuello
2.
J Cell Biol ; 154(4): 829-40, 2001 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-11502760

RESUMEN

Recent studies indicate that insulin stimulation of glucose transporter (GLUT)4 translocation requires at least two distinct insulin receptor-mediated signals: one leading to the activation of phosphatidylinositol 3 (PI-3) kinase and the other to the activation of the small GTP binding protein TC10. We now demonstrate that TC10 is processed through the secretory membrane trafficking system and localizes to caveolin-enriched lipid raft microdomains. Although insulin activated the wild-type TC10 protein and a TC10/H-Ras chimera that were targeted to lipid raft microdomains, it was unable to activate a TC10/K-Ras chimera that was directed to the nonlipid raft domains. Similarly, only the lipid raft-localized TC10/ H-Ras chimera inhibited GLUT4 translocation, whereas the TC10/K-Ras chimera showed no significant inhibitory activity. Furthermore, disruption of lipid raft microdomains by expression of a dominant-interfering caveolin 3 mutant (Cav3/DGV) inhibited the insulin stimulation of GLUT4 translocation and TC10 lipid raft localization and activation without affecting PI-3 kinase signaling. These data demonstrate that the insulin stimulation of GLUT4 translocation in adipocytes requires the spatial separation and distinct compartmentalization of the PI-3 kinase and TC10 signaling pathways.


Asunto(s)
Insulina/metabolismo , Microdominios de Membrana/metabolismo , Proteínas de Transporte de Monosacáridos/metabolismo , Proteínas Musculares , Proteínas de Unión al GTP rho/metabolismo , Adipocitos/citología , Secuencia de Aminoácidos , Animales , Caveolas , Caveolina 1 , Caveolinas/genética , Caveolinas/aislamiento & purificación , Células Cultivadas , Transportador de Glucosa de Tipo 4 , Ratones , Datos de Secuencia Molecular , Mutación , Transporte de Proteínas , Proteínas Recombinantes de Fusión/metabolismo , Transducción de Señal , Proteínas ras/genética , Proteínas de Unión al GTP rho/genética
3.
J Am Coll Cardiol ; 38(1): 232-7, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11451280

RESUMEN

OBJECTIVES: The aim of this study was to examine the effects of essential hypertension on cardiac autonomic function in type 2 diabetic patients. BACKGROUND: Hypertension is common in type 2 diabetic patients and is associated with a high mortality. However, the combined effects of type 2 diabetes and essential hypertension on cardiac autonomic function have not been fully elucidated. METHODS: Thirty-three patients with type 2 diabetes were assigned to a hypertensive diabetic group (n = 15; age: 56 +/- 8 years, mean +/- SD) or an age-matched normotensive diabetic group (n = 18, 56 +/- 6 years). Cardiac autonomic function was assessed by baroreflex sensitivity (BRS), heart rate variability (HRV), plasma norepinephrine concentration and cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphic findings. RESULTS: Baroreflex sensitivity was lower in the hypertensive diabetic group than it was in the normotensive diabetic group (p < 0.05). The early and delayed myocardial uptake of 123I-MIBG was lower (p < 0.01 and p < 0.05, respectively), and the percent washout rate of 123I-MIBG was higher (p < 0.05) in the hypertensive diabetic group. However, the high frequency (HF) power and the ratio of low frequency (LF) power to HF power (LF/HF) of HRV and plasma norepinephrine concentration were not significantly different. The homeostasis model assessment index was higher in the hypertensive diabetic group than it was in the normotensive diabetic group (p < 0.01). CONCLUSIONS: Our results indicate that essential hypertension acts synergistically with type 2 diabetes to depress cardiac reflex vagal and sympathetic function, and the results also suggest that insulin resistance may play a pathogenic role in these processes.


Asunto(s)
Sistema Nervioso Autónomo/fisiopatología , Diabetes Mellitus Tipo 2/fisiopatología , Angiopatías Diabéticas/fisiopatología , Corazón/inervación , Hipertensión/fisiopatología , 3-Yodobencilguanidina , Barorreflejo/fisiología , Femenino , Pruebas de Función Cardíaca , Frecuencia Cardíaca , Humanos , Resistencia a la Insulina/fisiología , Masculino , Persona de Mediana Edad , Norepinefrina/sangre , Radiofármacos
4.
Cardiovasc Res ; 35(2): 273-82, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9349390

RESUMEN

OBJECTIVE: Exposure to anoxia has been reported to activate ATP-sensitive potassium (K+(ATP)) channels in isolated ventricular myocytes. We aimed to investigate the mechanisms underlying the anoxia-induced activation of K+(ATP) channels. METHODS: Guinea pig ventricular myocytes were isolated using collagenase digestion. Action potentials and membrane currents were recorded in the whole-cell mode of patch clamp. Exposure to anoxia was performed in a semi-closed airtight chamber, which prevented the diffusion of atmospheric oxygen into anoxic perfusate. RESULTS: Exposure to glucose-free anoxia shortened the action potential duration (APD) to less than 20% of control in 13 +/- 3 min. Subsequent reoxygenation rapidly and completely restored the APD. The time-independent large outward current which developed during anoxia was completely suppressed by reoxygenation or by the application of glibenclamide, a K+(ATP) channel blocker. The presence of extracellular glucose did not prevent APD shortening during anoxia, although it significantly decreased the rate of shortening. Reoxygenation-induced restoration of the APD was inhibited after a long-lasting anoxia. In addition, repeated exposures to anoxia/reoxygenation progressively impaired the recovery of APD during reoxygenation. CONCLUSIONS: Activation of K+(ATP) channels occurs during anoxia. The primary source of ATP that regulates the channel activity seems to be oxidative phosphorylation. ATP derived from anaerobic glycolysis (attained by the increase of extracellular glucose) was observed to partially suppress the channel activity only when oxidative phosphorylation was severely impaired during anoxia.


Asunto(s)
Adenosina Trifosfato/metabolismo , Glucólisis , Hipoxia/metabolismo , Activación del Canal Iónico , Miocardio/metabolismo , Canales de Potasio/metabolismo , Potenciales de Acción , Animales , Gliburida/farmacología , Cobayas , Fosforilación Oxidativa , Técnicas de Placa-Clamp , Bloqueadores de los Canales de Potasio
5.
Am J Cardiol ; 70(13): 1185-9, 1992 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-1414944

RESUMEN

To determine whether left ventricular (LV) filling abnormalities in diabetes are associated with diabetic microangiopathy, and to evaluate the effect of a short-term glycemic control on the filling abnormalities, diastolic filling dynamics were assessed by pulsed Doppler echocardiography in 246 patients with non-insulin-dependent diabetics. Isovolumic relaxation time and the ratio of peak flow velocity of atrial filling wave to peak flow velocity of early filling wave (A/E) were significantly greater in diabetic patients than in age- and sex-matched control subjects. Diabetic patients with retinopathy had significantly greater isovolumic relaxation time and A/E values than those without retinopathy. A/E was significantly decreased 1 month after insulin treatment in those without, but not with retinopathy. It is concluded that LV diastolic filling is impaired in mildly hyperglycemic patients with non-insulin-dependent diabetes mellitus without severe complications, the abnormality being more intense in patients with retinopathy. A short-term glycemic control results in a marked decrease in abnormalities in patients without, but not with retinopathy.


Asunto(s)
Diabetes Mellitus Tipo 2/fisiopatología , Hiperglucemia/fisiopatología , Función Ventricular Izquierda/fisiología , Adulto , Anciano , Análisis de Varianza , Velocidad del Flujo Sanguíneo/fisiología , Distribución de Chi-Cuadrado , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/diagnóstico por imagen , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Retinopatía Diabética/diagnóstico por imagen , Retinopatía Diabética/fisiopatología , Diástole , Ecocardiografía/métodos , Femenino , Humanos , Hiperglucemia/tratamiento farmacológico , Hiperglucemia/etiología , Insulina/uso terapéutico , Masculino , Persona de Mediana Edad
6.
Br J Pharmacol ; 115(3): 381-2, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7582444

RESUMEN

A class Ib antiarrhythmic drug, mexiletine (100 microM) significantly shortened the action potential duration (APD) of guinea-pig ventricular muscles and this effect was completely abolished in the presence of glibenclamide (50 microM), a blocker of the ATP-sensitive K+ channel (KATP). Mexiletine significantly increased the open probability of uridine diphosphate-primed KATP channels, recorded in inside-out patches of the ventricular cells. The results suggest that mexiletine shortens the APD of ventricular muscles, at least in part, via activation of KATP.


Asunto(s)
Antiarrítmicos/farmacología , Gliburida/farmacología , Ventrículos Cardíacos/efectos de los fármacos , Mexiletine/farmacología , Canales de Potasio/efectos de los fármacos , Potenciales de Acción/efectos de los fármacos , Adenosina Trifosfato/farmacología , Animales , Estimulación Eléctrica , Cobayas , Ventrículos Cardíacos/citología , Ventrículos Cardíacos/metabolismo , Microelectrodos , Músculos Papilares/efectos de los fármacos , Técnicas de Placa-Clamp , Bloqueadores de los Canales de Potasio , Uridina Difosfato/farmacología
7.
Br J Pharmacol ; 130(4): 767-76, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10864882

RESUMEN

A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective. However, the precise mechanism underlying the cardioprotective effect of this drug is unknown. Coronary-perfused guinea-pig ventricular muscles were subjected to 20-min no-flow ischaemia followed by 60-min reperfusion (I/R). I/R significantly decreased the contraction in untreated preparations (control group, 34+/-4% of baseline value, n=6). Brief administration of JT (1.0 microM) prior to ischaemia significantly improved the postischaemic contractile recovery (63+/-5% of baseline value, n=4), as compared to the control group. JT (1.0 microM) slightly prolonged action potential duration before ischaemia and induced conduction disturbance (2 : 1 block) after the initiation of ischaemia. The cardioprotective effect of JT was antagonized by chelerythrine (CH, 5.0 microM), an inhibitor of protein kinase C (PKC) or by 5-hydroxydecanoic acid (5-HD, 400 microM), an inhibitor of mitochondrial ATP-sensitive K(+) (K(ATP)) channels. These results suggest that the protective effect of JT is due to the opening of mitochondrial K(ATP) channels, which, in turn, is linked to PKC activation.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Ventrículos Cardíacos/efectos de los fármacos , Contracción Miocárdica/efectos de los fármacos , Daño por Reperfusión Miocárdica/prevención & control , Tiazepinas/farmacología , Potenciales de Acción/efectos de los fármacos , Adenosina Trifosfato/fisiología , Alcaloides , Animales , Benzofenantridinas , Ácidos Decanoicos/farmacología , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Cobayas , Hidroxiácidos/farmacología , Técnicas In Vitro , Mitocondrias Cardíacas/efectos de los fármacos , Mitocondrias Cardíacas/fisiología , Isquemia Miocárdica/complicaciones , Reperfusión Miocárdica/efectos adversos , Daño por Reperfusión Miocárdica/etiología , Perfusión , Fenantridinas/farmacología , Canales de Potasio/efectos de los fármacos , Canales de Potasio/metabolismo , Proteína Quinasa C/antagonistas & inhibidores , Proteína Quinasa C/metabolismo , Función Ventricular
8.
J Endocrinol ; 147(3): 479-85, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8543918

RESUMEN

Cellular and nuclear uptake of tri-iodothyronine (T3) and thyroxine (T4) was examined using the cultured cell line derived from rat liver, clone 9, and rat hepatoma, dRLH-84. The saturable cellular uptake of T3 and T4 was demonstrated in these cells. First we examined the cell cycle-dependent alteration of thyroid hormone uptake. Cellular T3 uptake was minimal in the early G1 phase and increased in the late G1 phase, reaching a maximal level in the S phase. Alterations in nuclear T3 uptake were in accordance with the changes in cellular T3 uptake. On the other hand, cellular and nuclear T4 uptake was unchanged throughout the cell cycle, suggesting the T3 specificity of the cell cycle-dependent alteration of cellular hormone transport. Next we examined the effect of sodium butyrate on the cellular transport of thyroid hormones. After treatment with 5 mM sodium butyrate, cellular and nuclear uptake of T3 was increased, reaching a maximal level (four- to sevenfold increase) after 48 h. When cells were incubated for 48 h with various concentrations of sodium butyrate, T3 uptake was enhanced by 1 mM sodium butyrate, reaching a maximal level with 5 mM. Although cellular T4 uptake was also increased after treatment with sodium butyrate, the degree and time-course of the increase were different from those of T3. The maximal increase in cellular T4 uptake (two- to threefold increase) was attained 20 h after treatment. Despite the increase in cellular T4 uptake, nuclear T4 uptake was decreased after treatment with sodium butyrate. For both T3 and T4, the enhanced cellular uptake was due to the increased Vmax without changes in the Michaelis-Menten constant. These data indicate that cellular transport of T4 is different from that of T3 in rat hepatic cells.


Asunto(s)
Ciclo Celular/fisiología , Hígado/metabolismo , Tiroxina/metabolismo , Triyodotironina/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Butiratos/farmacología , Ácido Butírico , Línea Celular , Núcleo Celular/metabolismo , Células Cultivadas , Citometría de Flujo , Fase G1 , Ratas , Receptores de Hormona Tiroidea/metabolismo , Fase S
9.
J Steroid Biochem Mol Biol ; 52(4): 365-73, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7734405

RESUMEN

FK143 is a nonsteroidal new inhibitor of steroid 5 alpha-reductase, an enzyme which converts testosterone into 5 alpha-dihydrotestosterone (DHT). We studied in vivo effects of FK143 on rat and dog prostates. FK143 was orally administered to mature male rats for 14 days. At doses above 1 mg/kg, FK143 significantly reduced the wet weights of the ventral prostate and seminal vesicle, but showed no effects on those of the epididymis, testis, and adrenal. Growth of ventral prostate and seminal vesicle was induced by the subcutaneous injection of testosterone propionate (TP) in the castrated young rats and was reduced by FK143 administration at doses above 3.2 mg/kg, while growth induced by 5 alpha-dihydrotestosterone propionate (DHTP) was not affected. FK143 had no binding affinity for the rat androgen receptor. FK143 showed neither estrogenic and antiestrogenic effects on the rat uterus nor androgenic effect on the rat prostate. Concentration of testosterone and DHT in the rat and dog prostates were measured by GC-MS, and administration of 10 mg/kg of FK143 significantly reduced the intraprostatic concentration of DHT. These results indicate that FK143 reduced the prostate growth by inhibiting 5 alpha-reductase activities in the prostates.


Asunto(s)
Inhibidores de 5-alfa-Reductasa , Indoles/farmacología , Fenilbutiratos/farmacología , Próstata/efectos de los fármacos , Administración Oral , Factores de Edad , Andrógenos/análisis , Animales , Citosol , Dihidrotestosterona/análisis , Perros , Femenino , Masculino , Orquiectomía , Tamaño de los Órganos/efectos de los fármacos , Próstata/química , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Receptores Androgénicos/análisis , Vesículas Seminales/efectos de los fármacos , Factores Sexuales , Testosterona/análisis , Útero/efectos de los fármacos
10.
Naunyn Schmiedebergs Arch Pharmacol ; 357(3): 283-90, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9550300

RESUMEN

The effects of various class I antiarrhythmic drugs and glibenclamide were examined on the recovery of contraction during reperfusion, in relation to the action potential duration (APD) seen during ischemia. Action potential and contractile tension were recorded from isolated guinea pig right ventricular muscles perfused with oxygenated Tyrode solution via the coronary artery. Ten minutes of no-flow ischemia shortened the APD at 90% of repolarization level (APD90) to 58% of control (pre-ischemic values). The APD90 was completely restored after 60 min of reperfusion. The developed tension was abolished during ischemia and recovered to 87% of control after 60 min of reperfusion. In the presence of Vaughan Williams class Ia drug cibenzoline (5 microM) or an ATP-sensitive potassium (K(ATP)) channel blocker glibenclamide (10 microM), the shortening of the APD90 during ischemia was significantly attenuated. However, the recovery of developed tension was significantly inhibited. Class Ic drug pilsicainide (10 microM) did not affect the ischemia-induced shortening of the APD90 or the recovery of developed tension after reperfusion. In the presence of class Ib drug mexiletine (10 microM), the shortening of the APD90 during ischemia was significantly facilitated. The recovery of developed tension in the presence of mexiletine tended to be improved, although the difference was not statistically significant. The developed tension measured after the 60 min reperfusion period following 20 min of no-flow ischemia was markedly depressed, indicating the presence of myocardial stunning. Mexiletine and pilsicainide significantly improved the recovery of developed tension and diminished the stunning. We conclude that cibenzoline and glibenclamide, which block cardiac K(ATP) channels inhibit contractile recovery after reperfusion by attenuating the shortening of APD during ischemia. In contrast, mexiletine, which activates K(ATP) channels (in addition to blockade of Na+ channels) improves contractile recovery by facilitating the shortening of APD during ischemia.


Asunto(s)
Antiarrítmicos/farmacología , Corazón/efectos de los fármacos , Aturdimiento Miocárdico/tratamiento farmacológico , Canales de Potasio/efectos de los fármacos , Animales , Gliburida/farmacología , Cobayas , Ventrículos Cardíacos/efectos de los fármacos , Imidazoles/farmacología , Lidocaína/análogos & derivados , Lidocaína/farmacología , Masculino , Mexiletine/farmacología , Aturdimiento Miocárdico/fisiopatología , Canales de Potasio/fisiología
11.
Diabetes Res Clin Pract ; 18(1): 1-9, 1992 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1446572

RESUMEN

A quantitative analysis of the molecular weight (MW) profile of urinary protein by SDS-PAGE was performed in streptozotocin (STZ)-injected, non-ketotic diabetic rats (DM group), diabetic rats receiving dipyridamole (DM-DIP group), normal rats (C group) and STZ-injected rats with near-normal glycemia due to insulin treatment (DM-INSULIN group). In the DM group, decrease of a small MW protein (SMWP) (MW 19.5 k) was found at 2.5 weeks, and an increase of larger MW proteins (LMWP) (MW 68 [albumin], 55 and 29 k) together with a decrease of SMWPs (MW 19.5 and 15 k) was found at 15 weeks, as compared to the C group: the MW profile of urinary protein in the DM-INSULIN and C groups was indistinguishable. At 15 weeks, creatinine clearance (Ccr) was significantly depressed and an increase in the mesangial matrix with electron dense deposits was evident in the DM group. The urinary protein abnormalities were partially corrected and the reduction of Ccr was absent in the DM-DIP group with no effect on glomerular morphology. STZ-induced diabetes in rats is accompanied by a reduction of urinary SMWP, and a subsequent increase of LMWP and depression of Ccr: dipyridamole ameliorates urinary protein abnormalities and prevents the reduction of Ccr.


Asunto(s)
Diabetes Mellitus Experimental/orina , Dipiridamol/farmacología , Insulina/uso terapéutico , Proteinuria , Animales , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/patología , Electroforesis en Gel de Poliacrilamida , Glomérulos Renales/patología , Glomérulos Renales/ultraestructura , Masculino , Microscopía Electrónica , Peso Molecular , Proteínas/aislamiento & purificación , Ratas , Ratas Wistar
12.
Am Psychol ; 56(1): 65-70, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11242990

RESUMEN

The development of family psychology and family therapy in Japan has occurred mostly since the 1980s. This development was originally activated by the major social issue in contemporary Japan of school refusal, in which more than 127,000 children either overtly refuse to or claim that they cannot go to school. From a family perspective, this problem is analyzed as it relates to the confusion that children experience from unbalanced and unclear boundaries in family relations or "membranes." An approach to family therapy that adapts systems theory and integrates a clay sculpting medium has been developed to work with Japanese families confronting this problem. The design and implementation of preventative family psychology programs applied at the community level are also an important part of the future development in these fields.


Asunto(s)
Terapia Familiar/métodos , Familia/psicología , Trastornos Mentales/terapia , Psicología/tendencias , Humanos , Japón
13.
Clin Nephrol ; 33(3): 130-5, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2182231

RESUMEN

The effect of 150 mg/day dipyridamole p.o. on urinary albumin excretion (UAE) was studied in 48 patients with diabetes mellitus without clinically discernible nephropathy. In 42 patients who were followed at an outpatient clinic, albumin/creatinine ratio (Ualb/Ucreat: mg/mmol) of untimed urine obtained from the same subjects repetitively was employed as an index of UAE. In 6 hospitalized patients, albumin excretion rate (AER) (micrograms/min) of 24-h-collected urine was determined. When followed without dipyridamole for 10.8 (the mean) months (N = 27, outpatients), the mean Ualb/Ucreat increased from 8.1 to 20.5. Of these, 11 patients with Ualb/Ucreat greater than 1.0 at the end of the observation period subsequently received dipyridamole for 4.2 months, and the ratio decreased from 49.0 to 7.3. When treated with dipyridamole for 9.0 months without a pre-treatment observation period (N = 15, outpatients), the ratio decreased from 9.8 to 5.6. AER of hospitalized patients who received dipyridamole for 10.0 days reduced from 68.0 to 21.9. All of these changes were statistically significant. Urinary beta 2 MG, blood pressure, serum creatinine and glycemic control were unaffected by the dipyridamole treatment. We conclude that dipyridamole reduces UAE in diabetic patients with subclinical level of albuminuria.


Asunto(s)
Albuminuria/tratamiento farmacológico , Complicaciones de la Diabetes , Nefropatías Diabéticas/complicaciones , Dipiridamol/uso terapéutico , Microglobulina beta-2/orina , Adulto , Anciano , Albuminuria/complicaciones , Presión Sanguínea , Diabetes Mellitus/fisiopatología , Diabetes Mellitus/orina , Nefropatías Diabéticas/fisiopatología , Nefropatías Diabéticas/orina , Femenino , Humanos , Masculino , Persona de Mediana Edad
14.
Pathol Res Pract ; 193(10): 727-32; discussion 733, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9505266

RESUMEN

A case of ganglioneuroblastoma occurring in the anterior mediastinum of a 79 year-old man is reported. The tumor was mainly composed of neuroblasts with occasional ganglion cells. Foci of melanin-laden cells were also identified. Immunohistochemistry revealed that the tumor cells showed both schwannian and melanocytic differentiation with immunoreactivity to anti-S100 protein and anti-HMB45 antibodies. In addition, the tumor contained several microcysts lined by squamous epithelial and one lymphoid tissue abundant in T lymphocytes, which appeared to be derived from thymic tissue. This case is unique in that neuroblastoma group tumors including ganglioneuroblastoma is uncommon in the elderly and in the thymic region, and rarely shows melanocytic differentiation. To the best of our knowledge, this case is a tumor of neuroblastoma group occurring in the eldest patient.


Asunto(s)
Ganglioneuroblastoma/patología , Neoplasias del Mediastino/patología , Anciano , Biomarcadores de Tumor , Diferenciación Celular , Quimioterapia Adyuvante , Cisplatino/uso terapéutico , Etopósido/uso terapéutico , Ganglioneuroblastoma/tratamiento farmacológico , Ganglioneuroblastoma/cirugía , Humanos , Inmunohistoquímica , Masculino , Neoplasias del Mediastino/tratamiento farmacológico , Neoplasias del Mediastino/cirugía , Melanocitos/ultraestructura
16.
Intern Med ; 40(9): 931-5, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11579959

RESUMEN

A 45-year-old male was admitted because of chest pain, lumbago, and bilateral ankle pain. Examination disclosed hypophosphatemic osteomalacia, acquired Fanconi syndrome, and abnormalities in distal nephron such as distal renal tubular acidosis and renal diabetes insipidus. Further exploration revealed IgA kappa multiple myeloma excreting urinary Bence Jones protein (kappa-light chain). Renal biopsy revealed thick basement membranes and elec-tron-dense crystals in proximal tubular epithelial cells. Immunofluorescent studies revealed deposition of kappa-light chain in renal tubular epithelial cells that caused the renal tubular damage. Although the osteomalacia was relieved by medical treatment, the urinary Bence Jones protein and the renal tubular defects were not improved by the chemotherapy for the myeloma. The patient died of exacerbation of multiple myeloma at 50 years of age.


Asunto(s)
Inmunoglobulina A , Cadenas kappa de Inmunoglobulina , Neoplasias Renales/diagnóstico , Neoplasias Renales/metabolismo , Túbulos Renales Distales/patología , Túbulos Renales Proximales/patología , Riñón/metabolismo , Mieloma Múltiple/diagnóstico , Mieloma Múltiple/metabolismo , Biopsia , Resultado Fatal , Humanos , Riñón/patología , Neoplasias Renales/complicaciones , Neoplasias Renales/patología , Masculino , Persona de Mediana Edad , Mieloma Múltiple/complicaciones , Mieloma Múltiple/patología , Osteomalacia/etiología , Factores de Tiempo
17.
Angiology ; 43(1): 40-6, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1532485

RESUMEN

The physiology of atrial natriuretic peptide (ANP) secretion was studied in normotensive subjects and hypertensive patients both young and old. Basal plasma ANP concentration was least in young normotensives, intermediate in old normotensives and young hypertensives, and highest in old hypertensives. Nifedipine, a known stimulator of ANP secretion, acutely increased plasma ANP in young and old normotensive subjects but not in young hypertensive patients and half of the old hypertensive patients. Increase in serum ANP level in response to nifedipine did not augment its hypotensive effect. However, the increase of aldosterone in response to nifedipine-induced rise in plasma renin activity (PRA) seemed to be suppressed by elevated ANP.


Asunto(s)
Factor Natriurético Atrial/efectos de los fármacos , Hipertensión/tratamiento farmacológico , Nifedipino/farmacología , Adulto , Anciano , Factor Natriurético Atrial/sangre , Presión Sanguínea/efectos de los fármacos , Cardiomegalia/sangre , Cardiomegalia/tratamiento farmacológico , Cardiomegalia/fisiopatología , Electrocardiografía/efectos de los fármacos , Femenino , Humanos , Hipertensión/sangre , Hipertensión/fisiopatología , Masculino , Persona de Mediana Edad , Pulso Arterial/efectos de los fármacos , Sistema Renina-Angiotensina/efectos de los fármacos
18.
Psychiatry ; 63(4): 371-84, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11218560

RESUMEN

Clinical work with minorities in Japan is a relatively new and rapidly growing field. An influx of migrants from the 1970s has required psychiatrists to work with culturally different patients, yet few are experienced or trained in this area. With an even more radical population change imminent, skills in working with people of diverse cultural backgrounds are becoming a pressing need. While psychiatry in Japan has long been concerned with culture, only very recently has this concern involved differences among Japanese. Psychotherapy with both new migrants and individuals from more traditional minority backgrounds involves issues of acculturation and identity. A clinical approach based on a theoretical orientation of constructivistic narrative therapy can be usefully applied to multicultural situations. A case is presented in which this approach is employed in assisting a Korean-Japanese youth to deal with identity struggles.


Asunto(s)
Cultura , Lenguaje , Grupos Minoritarios/psicología , Psiquiatría , Psicoterapia/métodos , Autoimagen , Aculturación , Adulto , Femenino , Humanos , Japón , Corea (Geográfico)/etnología
19.
Am J Orthopsychiatry ; 69(4): 482-94, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10553459

RESUMEN

Psychotherapeutic work in Japan with minority populations requires an understanding of their specific social and cultural context. Clinical case studies of individuals of burakumin, Korean, and mixed ancestry illustrate the complex issues of prejudice, discrimination, legal contraints, state ideology, and popular mythology of homogeneity that each brings to counseling. Clinical approaches, guided by a multicultural counseling and therapy framework, are discussed.


Asunto(s)
Cultura , Grupos Minoritarios/psicología , Apoyo Social , Adulto , Consejo , Diversidad Cultural , Femenino , Humanos , Japón , Corea (Geográfico)/etnología , Masculino , Psicoterapia/métodos , Estrés Psicológico/psicología , Estrés Psicológico/terapia , Estados Unidos/etnología
20.
Kurume Med J ; 45(2): 175-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9715044

RESUMEN

The therapeutic role of interleukin (IL)-1 receptor antagonist, a potent inhibitor of IL-1, was investigated using peripheral blood mononuclear cells from patients with ulcerative colitis and Crohn's disease. Administration of IL-1 receptor antagonist inhibited IL-1 beta-augmented IL-1 alpha and tumor necrosis factor-alpha production by mononuclear cells. Prednisolone caused a decrease in IL-1 receptor antagonist release, whereas sulfasalazine had no modulatory effect. Interestingly, IgG caused an increase in IL-1 receptor antagonist release. In conclusion, IL-1 receptor antagonist and related molecules may have therapeutic value.


Asunto(s)
Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Receptores de Interleucina-1/antagonistas & inhibidores , Células Cultivadas , Evaluación Preclínica de Medicamentos , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA